finasteride has been researched along with Innate Inflammatory Response in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Caruso, D; Cioffi, L; Diviccaro, S; Falvo, E; Giatti, S; Herian, M; Melcangi, RC | 1 |
| De Marzo, AM; Drake, CG; Goodman, PJ; Isaacs, WB; Johnson-Pais, TL; Leach, RJ; Lippman, SM; Lucia, MS; Parnes, HL; Platz, EA; Santella, RM; Tangen, CM; Thompson, IM; Till, C; Winchester, DA; Xu, J; Zheng, SL | 1 |
| Abiola, OJ; Adaramoye, OA; Akanni, OO; Akinloye, O; Olapade-Olaopa, EO; Owumi, SE | 1 |
| An, HJ; Chung, KS; Jin, BR; Kim, HJ | 1 |
| Culig, Z; Madersbacher, S; Sampson, N | 1 |
| Kristal, A; Platz, EA; Thompson, I | 1 |
| Cai, W; Guo, Y; Jiang, Y; Li, W; Wang, X; Yang, S | 1 |
| Barber, JR; De Marzo, AM; Drake, CG; Goodman, PJ; Gurel, B; Kristal, AR; Lippman, SM; Lucia, MS; Murtola, TJ; Nelson, WG; Parnes, HL; Peskoe, SB; Platz, EA; Sutcliffe, S; Thompson, IM; Umbehr, M | 1 |
| Park, DS; Shim, JY | 1 |
| Pitts, WR | 1 |
| Canby-Hagino, ED; Thompson, IM | 1 |
| Piérard, GE; Piérard-Franchimont, C | 1 |
| Leskinen, M; Lukkarinen, O; Marttila, T | 1 |
4 review(s) available for finasteride and Innate Inflammatory Response
| Article | Year |
|---|---|
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
Prevention of prostate cancer: outcomes of clinical trials and future opportunities.
Topics: Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Finasteride; Humans; Inflammation; Male; Middle Aged; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin E | 2014 |
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
Topics: Androgens; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chemoprevention; Diet; Enzyme Inhibitors; Epidemiologic Studies; Finasteride; Humans; Inflammation; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 2005 |
[Male alopecia: etiopathogenic concepts and current therapies].
Topics: 5-alpha Reductase Inhibitors; Alopecia; Female; Finasteride; Humans; Inflammation; Male; Minoxidil; Severity of Illness Index; Vasodilator Agents | 1997 |
2 trial(s) available for finasteride and Innate Inflammatory Response
| Article | Year |
|---|---|
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Topics: Aged; Biopsy; Finasteride; Genetic Association Studies; Humans; Inflammation; Interleukin-10; Interleukin-8; Male; Middle Aged; Neoplasm Grading; Polymorphism, Single Nucleotide; Prostate; Prostatic Neoplasms; Urological Agents | 2017 |
Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study.
Topics: Adult; Chronic Disease; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Inflammation; Male; Middle Aged; Pelvic Pain; Pilot Projects; Syndrome | 1999 |
8 other study(ies) available for finasteride and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats.
Topics: Animals; Finasteride; Inflammation; Male; Pregnanolone; Pregnenolone; Rats; Receptors, GABA-A | 2022 |
Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Topics: Acetates; Animals; Apoptosis; Biomarkers; Cyclopentanes; Finasteride; Inflammation; Lipids; Male; Metabolic Detoxication, Phase I; Nitric Oxide; Organ Size; Oxylipins; Prostate; Prostatic Hyperplasia; Rats, Wistar; Testosterone; Weight Gain | 2017 |
Chinese Skullcap (Scutellaria baicalensis Georgi) inhibits inflammation and proliferation on benign prostatic hyperplasia in rats.
Topics: 5-alpha Reductase Inhibitors; Animals; Apoptosis; Biomarkers; Disease Models, Animal; Finasteride; Inflammation; Male; Medicine, Chinese Traditional; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Testosterone | 2019 |
Expression of Heat Shock Protein 27 in Benign Prostatic Hyperplasia with Chronic Inflammation.
Topics: Adrenergic alpha-Antagonists; Biomarkers, Tumor; CD3 Complex; Chronic Disease; Cross-Sectional Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Finasteride; Gene Expression Regulation; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Immunohistochemistry; Inflammation; Interleukin-6; Lower Urinary Tract Symptoms; Male; Molecular Chaperones; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Transurethral Resection of Prostate; Tumor Necrosis Factor-alpha | 2015 |
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
Topics: 5-alpha Reductase Inhibitors; Case-Control Studies; Finasteride; Humans; Inflammation; Male; Middle Aged; Prostate; Prostatic Neoplasms | 2016 |
Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antihypertensive Agents; CD3 Complex; Cyclooxygenase 2; Doxazosin; Enzyme Inhibitors; Finasteride; Glutathione Transferase; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Prostatic Hyperplasia; Prostatitis; Vascular Endothelial Growth Factor A | 2008 |
Re: inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale.
Topics: Enzyme Inhibitors; Finasteride; Humans; Inflammation; Male; Prostatic Neoplasms | 2004 |